Oxford BioMedica (UK) Ltd. is a UK-based research and development company specializing in biotechnology solutions. Established in 1995, the company operates from its Windrush Court address in Oxford, OX4 6LT. Oxford BioMedica is a limited company (Ltd.) with a strong focus on innovation and the development of novel products for the pharmaceutical and diagnostics industries. The company’s core business revolves around discovery and development of specialized reagents, antibodies, and related technologies. Oxford BioMedica’s expertise lies in providing custom synthesis, analytical services, and contract research to clients globally. They cater to a diverse range of needs, including antibody development, protein purification, and cell culture solutions. The company’s strategic focus is on providing high-quality, technically advanced solutions. While primarily focused on internal research and development, Oxford BioMedica maintains an international presence through collaborations and partnerships. They are actively involved in market analysis and trend identification, anticipating future industry needs. Currently, Oxford BioMedica is a global business, actively seeking to expand its international reach. The company is currently a Worker (A rating) with Visa: Global Business Mobility: Senior or Specialist Worker, and is registered under SIC Code: -72110.

Oxford BioMedica (UK) Ltd. is a UK-based research and development company specializing in biotechnology solutions. Established in 1995, the company operates from its Windrush Court address in Oxford, OX4 6LT. Oxford BioMedica is a limited company (Ltd.) with a strong focus on innovation and the development of novel products for the pharmaceutical and diagnostics industries. The company’s core business revolves around discovery and development of specialized reagents, antibodies, and related technologies. Oxford BioMedica’s expertise lies in providing custom synthesis, analytical services, and contract research to clients globally. They cater to a diverse range of needs, including antibody development, protein purification, and cell culture solutions. The company’s strategic focus is on providing high-quality, technically advanced solutions. While primarily focused on internal research and development, Oxford BioMedica maintains an international presence through collaborations and partnerships. They are actively involved in market analysis and trend identification, anticipating future industry needs. Currently, Oxford BioMedica is a global business, actively seeking to expand its international reach. The company is currently a Worker (A rating) with Visa: Global Business Mobility: Senior or Specialist Worker, and is registered under SIC Code: -72110.